[go: up one dir, main page]

CA922629A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
CA922629A
CA922629A CA012298A CA12298A CA922629A CA 922629 A CA922629 A CA 922629A CA 012298 A CA012298 A CA 012298A CA 12298 A CA12298 A CA 12298A CA 922629 A CA922629 A CA 922629A
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA012298A
Inventor
H. Smith Leslie
Howe Ralph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA922629A publication Critical patent/CA922629A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA012298A 1967-02-27 1968-02-12 Pharmaceutical compositions Expired CA922629A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61899467A 1967-02-27 1967-02-27
GB3855767 1967-08-22

Publications (1)

Publication Number Publication Date
CA922629A true CA922629A (en) 1973-03-13

Family

ID=26263851

Family Applications (1)

Application Number Title Priority Date Filing Date
CA012298A Expired CA922629A (en) 1967-02-27 1968-02-12 Pharmaceutical compositions

Country Status (6)

Country Link
BE (1) BE711349A (en)
CA (1) CA922629A (en)
DE (1) DE1667883A1 (en)
FR (1) FR8026M (en)
IE (1) IE31952B1 (en)
NL (1) NL6802588A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals

Also Published As

Publication number Publication date
IE31952B1 (en) 1973-02-21
FR8026M (en) 1970-08-03
IE31952L (en) 1968-08-27
NL6802588A (en) 1968-08-28
BE711349A (en) 1968-08-27
DE1667883A1 (en) 1971-08-12

Similar Documents

Publication Publication Date Title
MY7300271A (en) Pharmaceutical compositions
CY658A (en) Pharmaceutical compositions
CA922629A (en) Pharmaceutical compositions
MY7400206A (en) Pharmaceutical compositions
AU416723B2 (en) Pharmaceutical compositions
AU420795B2 (en) Pharmaceutical compositions
AU424759B2 (en) Pharmaceutical compositions
CA764398A (en) Pharmaceutical compositions
AU432427B2 (en) Pharmaceutical compositions
AU432988B2 (en) Pharmaceutical compositions
CA749898A (en) Alkali-generating compositions
CA761871A (en) Phytohormonal compositions
CA761411A (en) Pharmaceutical composition
AU1605167A (en) Pharmaceutical compositions
AU4706968A (en) Pharmaceutical compositions
AU4192368A (en) Pharmaceutical compositions
AU3430668A (en) Pharmaceutical compositions
AU3173567A (en) Pharmaceutical compositions
AU3030467A (en) Pharmaceutical compositions
AU2598867A (en) Pharmaceutical compositions
AU4214468A (en) Pharmaceutical compositions
IE32912L (en) Pharmaceutical compositions
AU1932267A (en) Therapeutic compositions
CA749983A (en) Pharmaceutical compositions comprising an arganine compound
AU419479B2 (en) Pharmaceutical compositions comprising alkaloids